Return to School Practices for Pediatric Hematopoietic Cell Transplant Recipients During COVID-19 Pandemic
While organizations such as Centers for Disease Control and Prevention and American Academy of Pediatrics have published guidelines favoring resumption of in-person schooling during COVID-19 pandemic, there is no specific guidance on hematopoietic cell transplant (HCT) recipients ’ safety of returning to school. We conducted a cross-sectional survey of pediatric HCT physician members of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) practicing in the United States (US) to describe current return to school practices during the COVID-19 pandemic for HC T recipients.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Neel S. Bhatt, Christa Meyer, Lih-Wen Mau, Larisa Broglie, Steven Devine, Sung Won Choi, Jeffery Auletta, Rachel Phelan Source Type: research
More News: Academies | Biology | Centers for Disease Control and Prevention (CDC) | COVID-19 | Hematology | Pandemics | Pediatrics | Transplants | USA Health